Palbociclib in Treating Patients With Metastatic HER-2 Positive Breast Cancer With Brain Metastasis

Clinical trial NCT02774681 · TERMINATED

Trial details

NCT number: NCT02774681
Sponsor: Northwestern University
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Carcinoma Metastatic in the Brain Estrogen Receptor Negative HER2/Neu Negative HER2/Neu Positive Progesterone Receptor Negative Recurrent Breast Carcinoma Stage IV Breast Cancer

Start date: 2016-08-31
Primary completion: 2019-02-13
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.